Mold / CIRS
Evidence-based research on mycotoxin exposure, Chronic Inflammatory Response Syndrome, and detox protocols — from HLA-DR genetics and biotoxin pathways to binder strategies and immune recovery.
What Is Mold Illness / CIRS?
Chronic Inflammatory Response Syndrome (CIRS) is a multi-system, multi-symptom illness caused by exposure to biotoxins — most commonly from water-damaged buildings containing mold species like Stachybotrys chartarum, Aspergillus, Penicillium, and Chaetomium. These organisms produce mycotoxins, volatile organic compounds (VOCs), and beta-glucans that trigger a devastating inflammatory cascade in genetically susceptible individuals.
The key genetic factor is HLA-DR haplotype. Approximately 24% of the population carries HLA-DR genotypes that prevent the immune system from recognizing and clearing biotoxins. In these individuals, mycotoxins are not tagged for removal — they recirculate endlessly, triggering the innate immune system to produce inflammatory cytokines in a self-perpetuating loop. This is why some people develop severe illness from mold exposure while others in the same building remain unaffected.
The biotoxin pathway, mapped by Dr. Ritchie Shoemaker, describes the cascade: mycotoxin exposure leads to cytokine elevation, which suppresses melanocyte-stimulating hormone (MSH) and vasoactive intestinal peptide (VIP), disrupts antidiuretic hormone (ADH) and osmolality regulation, elevates matrix metalloproteinase-9 (MMP-9) and transforming growth factor beta-1 (TGF-beta 1), activates complement (C4a), and ultimately creates widespread inflammation affecting the brain, gut, hormones, immune system, and connective tissues simultaneously.
Key Mechanisms
The major pathological drivers identified in mold illness and CIRS research:
Mycotoxin Exposure
Mold species like Aspergillus, Stachybotrys, and Penicillium produce potent mycotoxins — trichothecenes, ochratoxin A, gliotoxin, and aflatoxins — that damage cell membranes, disrupt mitochondrial function, suppress immune response, and generate massive oxidative stress across multiple organ systems.
HLA-DR Genetics
Approximately 24% of the population carries HLA-DR genotypes that prevent the immune system from properly tagging and clearing biotoxins. These individuals cannot form the antibodies needed to remove mycotoxins, leading to chronic recirculation and accumulation — the genetic basis of why some people get sick from mold while others do not.
Biotoxin Pathway
When biotoxins are not cleared, they trigger a cascading inflammatory response through the innate immune system. Cytokines rise, complement activation occurs, TGF-beta 1 and MMP-9 elevate, MSH drops, and VIP is suppressed — creating a self-perpetuating cycle of inflammation that Ritchie Shoemaker mapped as the biotoxin pathway.
Multi-System Impact
Mold illness is not a single-organ disease. Mycotoxins cross the blood-brain barrier causing neurological symptoms, disrupt gut barrier integrity triggering food sensitivities, suppress hormones (MSH, VIP, ADH), dysregulate the immune system, and impair detoxification pathways — making it one of the most complex multi-system conditions to treat.
Common Symptoms
Research on MyBioHack
Blog Articles
In-depth articles covering mycotoxin exposure, biotoxin illness pathophysiology, mold remediation, detox protocols, and evidence-based recovery strategies for CIRS.
Browse articlesJD Guide Chapters
Premium chapters in the Junction Dysfunction Guide covering biotoxin pathways, HLA-DR genetics, binder protocols, immune dysregulation, and multi-system recovery from mold illness.
Explore chaptersLab Tests
Targeted lab panels to assess mycotoxin levels, inflammatory markers (TGF-beta 1, MMP-9, C4a), HLA-DR genotyping, MSH, VIP, and ADH levels.
View lab testsRecovery Approaches
Key areas that evidence and clinical experience point to for meaningful mold illness and CIRS recovery:
Mold Avoidance
The foundation of any CIRS recovery protocol. Identifying and remediating the source of exposure — whether water-damaged buildings, contaminated food, or environmental reservoirs — is non-negotiable. No amount of supplementation will overcome ongoing exposure.
Binders & Detox Support
Cholestyramine (CSM), activated charcoal, bentonite clay, and chlorella bind mycotoxins in the gut and prevent reabsorption through enterohepatic recirculation. Glutathione, NAC, and phase II liver support accelerate systemic detoxification.
Immune Modulation
Addressing the dysregulated innate immune response with VIP nasal spray, low-dose naltrexone (LDN), omega-3 fatty acids, and targeted cytokine modulation. Restoring MSH and VIP levels is critical for breaking the inflammatory cascade.
Nasal & Sinus Protocols
MARCoNS (Multiple Antibiotic Resistant Coagulase Negative Staphylococci) colonization in the nasal passages is common in CIRS patients. BEG spray, nasal rinses, and biofilm disruptors target this persistent infection that blocks MSH recovery.
Work With Jacob on a Mold Illness Recovery Protocol
Jacob has worked with dozens of clients navigating mold illness and CIRS. Book a one-on-one consultation to get a protocol tailored to your labs, HLA-DR genotype, and symptom presentation — covering mycotoxin binders, immune modulation, nasal protocols, and environmental remediation guidance.
Book a ConsultationHave questions about mold illness?
Get personalized, research-backed answers from the Biohacking Bot.
Ask About Mold Illness Protocols